Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Jordan

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The AAPS Journal|August 14, 2021
An Alternative Data Transformation Approach for ADA Cut Point Determination: Why Not Use a Weibull Transformation?Gregor Jordan, Roland F Staack
Bioanalysis|February 10, 2023
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?Gregor Jordan, Roland F Staack
The AAPS Journal|January 23, 2026
Advancing Quantitative ADA Detection Through Model Informed Assay Development (MIAD)Gregor Jordan, Roland F Staack
Bioanalysis|July 8, 2020
Toward comparability of anti-drug antibody assays: is the amount of anti-drug antibody-reagent complexes at cut-point (CP-ARC) the missing piece?Gregor Jordan, Roland F Staack
Bioanalysis|March 8, 2012
Mathematical simulations for bioanalytical assay development: the (un-)necessity and (im-)possibility of free drug quantificationRoland F Staack, Gregor Jordan, Julia Heinrich
Bioanalysis|November 28, 2013
Free analyte QC concept: a novel approach to prove correct quantification of free therapeutic protein drug/biomarker concentrationsRoland F Staack, Gregor Jordan, Uwe Dahl, et al.
Bioanalysis|September 28, 2017
Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'Gregor Jordan, Ichio Onami, Julia Heinrich, et al.
Bioanalysis|January 21, 2017
3-(4-Hydroxyphenyl)propionic acid: the forgotten detection substrate for ligand-binding assay-based bioanalysisGregor Jordan, Kay-Gunnar Stubenrauch, Julia Heinrich, et al.
Bioanalysis|March 16, 2016
Platform switching from ELISA to Gyrolab™: a novel generic reagent omits the need to change critical reagentsGregor Jordan, Miriam Moheysen-Zadeh, Julia Heinrich, et al.
Bioanalysis|June 1, 2022
Novel isoelectric target depletion (ITaD) protocol reduces the need for specific reagents for immunogenicity testingGregor Jordan, Miriam Moheysen-Zadeh, Uwe Dahl, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The AAPS Journal|August 14, 2021
An Alternative Data Transformation Approach for ADA Cut Point Determination: Why Not Use a Weibull Transformation?Gregor Jordan, Roland F Staack
Bioanalysis|February 10, 2023
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?Gregor Jordan, Roland F Staack
The AAPS Journal|January 23, 2026
Advancing Quantitative ADA Detection Through Model Informed Assay Development (MIAD)Gregor Jordan, Roland F Staack
Bioanalysis|July 8, 2020
Toward comparability of anti-drug antibody assays: is the amount of anti-drug antibody-reagent complexes at cut-point (CP-ARC) the missing piece?Gregor Jordan, Roland F Staack
Bioanalysis|March 8, 2012
Mathematical simulations for bioanalytical assay development: the (un-)necessity and (im-)possibility of free drug quantificationRoland F Staack, Gregor Jordan, Julia Heinrich
Bioanalysis|November 28, 2013
Free analyte QC concept: a novel approach to prove correct quantification of free therapeutic protein drug/biomarker concentrationsRoland F Staack, Gregor Jordan, Uwe Dahl, et al.
Bioanalysis|September 28, 2017
Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'Gregor Jordan, Ichio Onami, Julia Heinrich, et al.
Bioanalysis|January 21, 2017
3-(4-Hydroxyphenyl)propionic acid: the forgotten detection substrate for ligand-binding assay-based bioanalysisGregor Jordan, Kay-Gunnar Stubenrauch, Julia Heinrich, et al.
Bioanalysis|March 16, 2016
Platform switching from ELISA to Gyrolab™: a novel generic reagent omits the need to change critical reagentsGregor Jordan, Miriam Moheysen-Zadeh, Julia Heinrich, et al.
Bioanalysis|June 1, 2022
Novel isoelectric target depletion (ITaD) protocol reduces the need for specific reagents for immunogenicity testingGregor Jordan, Miriam Moheysen-Zadeh, Uwe Dahl, et al.
Pageof 4